US 12,258,351 B2
Sesquiterpenoid derivative and use thereof in preparing broad-spectrum antiviral drug
Min Xu, Kunming (CN); and Shaoxing Dai, Kunming (CN)
Assigned to KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY, Kunming (CN)
Filed by KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY, Yunan (CN)
Filed on Apr. 2, 2024, as Appl. No. 18/625,188.
Application 18/625,188 is a continuation of application No. PCT/CN2022/086210, filed on Apr. 12, 2022.
Claims priority of application No. 202210291346.6 (CN), filed on Mar. 23, 2022.
Prior Publication US 2024/0270754 A1, Aug. 15, 2024
Int. Cl. C07D 493/10 (2006.01); A61K 31/35 (2006.01); A61P 31/14 (2006.01)
CPC C07D 493/10 (2013.01) [A61K 31/35 (2013.01); A61P 31/14 (2018.01)] 5 Claims
OG exemplary drawing
 
1. A method for treating diseases caused by infection of a virus, comprising
administering the compound of Formula I to a subject in need of treatment thereof,
wherein the compound of Formula I has a following structure:

OG Complex Work Unit Chemistry
wherein, R1 is p-hydroxybenzoyl group, and
wherein the viruse is selected from a group consisting of Covid-19 and vesicular stomatitis virus.